Integrative transcriptomic analysis of non-small cell lung cancer: Microenvironment, circulation, and metastasis

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Network Modeling Analysis in Health Informatics and Bioinformatics

• Publication date

  2025-11-11

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1007/s13721-025-00640-z
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion

  2025cited by this paper
• The crucial role of SPP1 in osteoporosis, osteoarthritis, and cancer

  2025cited by this paper
• MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience

  2025cited by this paper
• Role of osteopontin in cancer: From pathogenesis to therapeutics (Review)

  2025cited by this paper
• Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer

  2024cited by this paper
• The significant others of aurora kinase a in cancer: combination is the key

  2024cited by this paper
• A Comprehensive Review of HER2 in Cancer Biology and Therapeutics

  2024cited by this paper
• Metabolic Vulnerabilities in Cancer: A New Therapeutic Strategy.

  2024cited by this paper
• Cellular Senescence in Lung Cancer: Molecular Mechanisms and Therapeutic Interventions.

  2024cited by this paper
• High Ki67 Gene Expression Is Associated With Aggressive Phenotype in Hepatocellular Carcinoma

  2024cited by this paper
• Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors

  2024cited by this paper
• Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy.

  2024cited by this paper
• Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma

  2024cited by this paper
• The role of cell cycle-related genes in the tumorigenesis of adrenal and thyroid neuroendocrine tumors

  2024cited by this paper
• Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications

  2024cited by this paper
• Syndecan-1: a key player in health and disease

  2024cited by this paper
• Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions

  2024cited by this paper
• Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics

  2023cited by this paper
• EP12.01-59 Tepotinib and Capmatinib in Patients with MET exon 14 Skipping NSCLC: A Matching Adjusted Indirect Comparison (MAIC)

  2023cited by this paper
• Capture of circulating metastatic cancer cell clusters from lung cancer patients can reveal unique genomic profiles and potential anti-metastatic molecular targets: A proof-of-concept study

  2023cited by this paper
• Bronchoalveolar Lavage as Potential Diagnostic Specimens to Genetic Testing in Advanced Nonsmall Cell Lung Cancer

  2023cited by this paper
• Clinical features and treatment of bone marrow metastasis

  2023cited by this paper
• Identification of the potential ferroptosis key genes in lung cancer with bone metastasis

  2023cited by this paper
• Targeting CDK1 in cancer: mechanisms and implications

  2023cited by this paper
• The Significance of SPP1 in Lung Cancers and Its Impact as a Marker for Protumor Tumor-Associated Macrophages

  2023cited by this paper
• Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming

  2023cited by this paper
• Significance of circulating tumor cells in lung cancer: a narrative review

  2023cited by this paper
• Erb-b2 receptor tyrosine kinase 2 interaction with growth factor receptor bound protein 7 acts as a molecular switch to activate non-small cell lung cancer: An in silico prediction

  2023cited by this paper
• Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations

  2022cited by this paper
• The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development

  2022cited by this paper
• The prediction of lung cancer prognosis with blood lipid levels and ratios at the time of diagnosis

  2022cited by this paper
• An evaluation of KIF20A as a prognostic factor and therapeutic target for lung adenocarcinoma using integrated bioinformatics analysis

  2022cited by this paper
• Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer

  2022cited by this paper
• HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies

  2022cited by this paper
• The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma

  2022cited by this paper
• HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies

  2022cited by this paper
• Comprehensive Bioinformatics Analysis to Identify the Gene HMMR Associated With Lung Adenocarcinoma Prognosis and Its Mechanism of Action in Multiple Cancers

  2021cited by this paper
• Prognostic significance of KRT19 in Lung Squamous Cancer

  2021cited by this paper
• Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy

  2021cited by this paper
• Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Gene Set Knowledge Discovery with Enrichr

  2021cited by this paper
• Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance

  2021cited by this paper
• Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.

  2021cited by this paper
• Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation

  2021cited by this paper
• Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis

  2021cited by this paper
• CDK inhibitors in cancer therapy, an overview of recent development.

  2021cited by this paper
• Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma

  2021cited by this paper
• Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis

  2021cited by this paper
• Targeting PI3K/Akt signal transduction for cancer therapy

  2021cited by this paper
• Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan

  2020cited by this paper
• High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma

  2020cited by this paper
• The importance of Ki-67 proliferation index in small cell lung cancer

  2020cited by this paper
• The epidemiology and biology of pulmonary metastases

  2020cited by this paper
• Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?

  2020cited by this paper
• In vitro antiproliferative activity of cold atmospheric plasma on small-cell lung carcinoma

  2020cited by this paper
• Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer

  2020cited by this paper
• A non-proliferative role of pyrimidine metabolism in cancer

  2020cited by this paper
• Silibinin Induces G2/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer

  2020cited by this paper
• High expression of TOP2A gene predicted poor prognosis of hepatocellular carcinoma after radical hepatectomy

  2020cited by this paper
• TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma

  2020cited by this paper
• Prognostic significance of KIF2A and KIF20A expression in human cancer

  2019cited by this paper
• Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer

  2019cited by this paper
• Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer

  2018cited by this paper
• Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA.

  2018cited by this paper
• SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker

  2018cited by this paper
• STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

  2018cited by this paper
• Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis

  2018cited by this paper
• Syndecan-1 Controls Lung Tumorigenesis by Regulating miRNAs Packaged in Exosomes.

  2018cited by this paper
• Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

  2018cited by this paper
• GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

  2017influential reference
• Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

  2016cited by this paper
• Prognostic role of cyclin B1 in solid tumors: a meta-analysis

  2016cited by this paper
• Accuracy of Medicare Claim-based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases.

  2016cited by this paper
• Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I–III Non-Small Cell Lung Cancer

  2015cited by this paper
• Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

  2013cited by this paper
• Points of view: Heat maps

  2012cited by this paper
• Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion

  2009cited by this paper

• No citing papers are available for this paper.